Single tRNA controls prostate cancer identity and treatment resistance
Researchers at Fred Hutch Cancer Center have identified a previously overlooked molecular regulator that helps determine whether prostate tumors remain sensitive to treatment or evolve into a more aggressive, drug-resistant form of the disease.
Read original article on The Medical News →Related news
-
Phthalate byproduct affects multiple cell types in human ovarian tissue, lab tests show
United Kingdom
-
Adults with ADHD face higher risk of developing dementia later in life
United Kingdom
-
Ancient gut microbes migrated with humans across the globe
United Kingdom
-
How your brain keeps learning while you rest
United Kingdom
-
IVF-conceived children show more 'jumping gene' DNA, study finds
United Kingdom
-
Strangers Showed Up to Man’s Destroyed House to Put Up a Tarp Having Seen His Televised Plea
United Kingdom
-
Parasitic worms could hold the key to treating immune system diseases
United Kingdom
-
Why Trump just loosened the rules on 'dyed diesel' — normally a farm fuel
United States